Head-To-Head Comparison: Alpha Tau Medical (NASDAQ:DRTS) vs. DarioHealth (NASDAQ:DRIO)

Alpha Tau Medical (NASDAQ:DRTS) and DarioHealth (NASDAQ:DRIO) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, profitability, dividends, analyst recommendations, earnings, institutional ownership and valuation.

Earnings and Valuation

This table compares Alpha Tau Medical and DarioHealth”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alpha Tau Medical	N/A	N/A	-$29.16 million	($0.45)	-6.67
DarioHealth	$28.03 million	1.13	-$59.43 million	($0.56)	-1.28

Alpha Tau Medical has higher earnings, but lower revenue than DarioHealth. Alpha Tau Medical is trading at a lower price-to-earnings ratio than DarioHealth, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Alpha Tau Medical and DarioHealth’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Alpha Tau Medical	N/A	-38.62%	-29.89%
DarioHealth	-205.62%	-72.16%	-40.74%

Analyst Ratings

This is a summary of current ratings and target prices for Alpha Tau Medical and DarioHealth, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alpha Tau Medical	0	0	2	0	3.00
DarioHealth	0	1	2	0	2.67

Alpha Tau Medical presently has a consensus price target of $8.00, indicating a potential upside of 166.67%. DarioHealth has a consensus price target of $2.00, indicating a potential upside of 178.55%. Given DarioHealth’s higher probable upside, analysts plainly believe DarioHealth is more favorable than Alpha Tau Medical.

Insider & Institutional Ownership

2.7% of Alpha Tau Medical shares are held by institutional investors. Comparatively, 33.4% of DarioHealth shares are held by institutional investors. 39.5% of Alpha Tau Medical shares are held by insiders. Comparatively, 10.9% of DarioHealth shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Risk and Volatility

Alpha Tau Medical has a beta of 0.92, suggesting that its stock price is 8% less volatile than the S&P 500. Comparatively, DarioHealth has a beta of 1.55, suggesting that its stock price is 55% more volatile than the S&P 500.

Summary

Alpha Tau Medical beats DarioHealth on 7 of the 12 factors compared between the two stocks.

About Alpha Tau Medical

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, prostate, and breast cancers; and preclinical studies for brain, hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.

About DarioHealth

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, pre-diabetes, hypertension, and weight management; Dario Move, which address most common musculoskeletal conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; and Dario One, a full suite of chronic condition management solution; and Dario blood glucose monitoring systems. It also provides native devices, such as glucose meter, blood pressure cuff, digital scale, and biofeedback sensor device, as well as live coaching services. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.